Author

admin

Browsing

The psychedelic drugs market is emerging as a strategic investment opportunity in healthcare, with forecasts generally placing its value around US$6.4 billion in 2025. This burgeoning sector is set for robust, double-digit compound annual growth, significantly driven by North America, which is anticipated to account for approximately 45–50 percent of…

Sranan Gold (CSE:SRAN,FSE:P84) is a junior exploration company focused on Suriname, a South American country that produces over 600,000 ounces of gold annually. The company’s flagship project is located in the highly prospective Guiana Shield, one of the world’s most underexplored and gold-rich geological regions. Sranan’s 29,000-hectare Tapanahony gold project…

The uranium market entered Q2 on shaky footing, with spot prices slipping to around US$63.50 per pound (March 13)—the lowest level in 18 months—as utilities hesitated to contract amid ample secondary supply and demand uncertainty. By early June, however, spot prices rebounded to the US$70–US$71 per pound range, buoyed by…

From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well. Read on to learn…